Release Date: 31/07/19 10:11 Summary: Settlement of Deferred Consideration Price Sensitive: Yes Download Document 250.32KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%